Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Carcinogenesis|August 1, 1997
Bioactivation of the mushroom hydrazine, agaritine, to intermediates that bind covalently to proteins and induce mutations in the Ames testK Walton, M M Coombs, F S Catterall, et al.
Mutation Research|May 30, 2001
Mutagenicity of bay-region amino-substituted cyclopenta[a]phenanthrenes and 2- and 5-aminochryseneF S Catterall, M M Coombs, C Ioannides, et al.
Carcinogenesis|August 1, 1988
Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthronesJ DiGiovanni, F H Kruszewski, M M Coombs, et al.
Carcinogenesis|March 1, 1992
Tumorigenicity of cyclopenta[a]phenanthrene derivatives and micronucleus induction in mouse skinR S Baker, A M Bonin, A Arlauskas, et al.
European Journal of Pharmacology|April 1, 1993
The metabolism and activation of 15,16-dihydrocyclopenta[a]phenanthren-17-one by cytochrome P-450 proteinsG W Boyd, R J Young, R G Harvey, et al.
Carcinogenesis|August 1, 1993
The in vitro metabolic activation of the 11-trifluoromethyl analogue of the potent carcinogen 15,16-dihydro-11-methyl-cyclopenta[a]-phenanthren-17-one to mutagensG W Boyd, H H Zepik, L M King, et al.
Toxicology|January 1, 1990
Induction of the P-450 I family of proteins by polycyclic aromatic hydrocarbons: possible relationship to their carcinogenicityA D Ayrton, M McFarlane, R Walker, et al.
Carcinogenesis|September 1, 1993
Cytochrome P450-dependent metabolism and mutagenicity of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one and their implications in its carcinogenicityG W Boyd, R J Young, R G Harvey, et al.
Carcinogenesis|October 1, 1995
Species variation in the metabolism of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to its 3,4-dihydrodiol, the proximate carcinogenG W Boyd, M M Coombs, C Ioannides, et al.
Cancer Research|June 1, 1985
Mechanism of mouse skin tumor promotion by chrysarobinJ DiGiovanni, P C Decina, W P Prichett, et al.
Pageof 5